Immune to Cancer: The CRI Blog
-
CICON17 Day 3 Recap: Combinations, Checkpoint Immunotherapy Resistance, Immunomodulators, and Microbiota
Day 3 of the CICON17 focused on combination therapies, immunomodulators, overcoming immune suppression, and the role bacteria in…
-
CICON17 Day 1 Recap: Neoantigens, Vaccines, and Overcoming Immunotherapy Resistance
Day 1 of CICON17 explored how to identify and target neoantigens with vaccines and other strategies to…
-
Highlights of the 2nd Annual Rational Combinations 360° Conference
Biomarkers will be crucial to taking advantage of combination immunotherapy’s full potential
-
ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference
ASCO17’s presentations reveal that the field of immunotherapy is advancing along many fronts
-
ASCO17: Days 4 and 5 Immunotherapy Highlights
Days 4 and 5 at ASCO17 showed off the overall scope of immunotherapy’s efforts to provide clinical…
-
ASCO17: Day 3 Immunotherapy Highlights
Day 3 at the 2017 annual meeting of the American Society of Clinical Oncology touched on immunotherapy…
-
ASCO17: Day 2 Immunotherapy Highlights
Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's…
-
ASCO17: Day 1 Immunotherapy Highlights
Day 1 at the 2017 annual meeting of the American Society of Clinical Oncology demonstrated immunotherapy’s potential…
-
ASCO17: Exploring the Past, Present, and Future of Immunotherapy
Immunotherapy is poised to shine at ASCO17